Skip to content

Isometric Exercise for Hypertension

Effectiveness and Mechanisms of Isometric Resistance Exercise to Reduce Blood Pressure in a Chinese Population: a Pilot Randomized-controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06515054
Enrollment
50
Registered
2024-07-23
Start date
2024-07-20
Completion date
2025-11-30
Last updated
2025-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

Background: Isometric resistance exercises (IREs) have great potential to improve blood pressure (BP) control. Methods: This is a pilot randomized controlled trial that will involve 50 patients with hypertension (HT) who do not meet the current physical activity guidelines defined by the World Health Organization. Participants will be randomly assigned in a 1:1 ratio using stratified and blocked randomization to either the IRE (wall squat) group or stretching exercise (active control) group. A well-structured, widely accepted, and validated 24-week wall squat program (2 minutes per exercise, 2 minutes of rest between sets, and 3 sessions per week) will be implemented, as it has been commonly used in previous research. All patients will be followed up for 24 weeks. Control group will receive exact same treatment except that IRE is replaced by frequency-matched and time-matched stretching exercise. The primary outcome measure will be rate of recruitment. Secondary outcomes will include BP parameters from 24-hour ambulatory BP monitoring

Interventions

BEHAVIORALwall squat

self-learnt wall squat exercise to be conducted for totally 24 weeks

time-matched passive stretching exercise to be conducted for totally 24 weeks

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* a suboptimal daytime SBP of \>135-160 mmHg on a 24-h ABPM * reported no regular physical activity or less than that recommended for adults by the World Health Organization (e.g. \<150 minutes of moderate-intensity aerobic exercise per week); * on stable doses of anti-HT medication(s) for ≥4 weeks if the patient is receiving drug treatments * agree for no drug changes during the intervention period (24 weeks);

Exclusion criteria

* cannot provide informed consent * unwillingness to repeat ABPM * relative contraindications to ABPM (i.e. diagnosed atrial fibrillation, nighttime workers, occupational drivers, or patients with bleeding tendencies) * severe osteoarthritis pending knee replacement surgery * known secondary HT * use of ≥3 anti-HT medications at maximum doses or ≥4 anti-HT medications * SBP or DBP are \>160 mmHg or \>100 mmHg, respectively, on ABPM * pregnancy/breastfeeding * active malignancy

Design outcomes

Primary

MeasureTime frameDescription
rate of recruitmentthrough study completion, an average of 1 yearnumber of people recruited per month

Secondary

MeasureTime frameDescription
Blood pressure parameters24-week after recruitment24-hour, daytime and nighttime blood pressure from 24-hour ambulatory systolic and diastolic blood pressure measurement
Carotid-femoral pulse wave velocity24-week after recruitmentanalysed by applanation tonometry using SphygmoCor (AtCor Medical Pty Ltd) with the accompanying SphygmoCor Software Suite (SphygmoCor System)
flow-mediated velocity (FMD)24-week after recruitmentFMD will be performed using a high-resolution linear artery transducer couple with a software (FMD suite, Quipu, Italy) that automatically detect and measure the brachial artery diameter and will be performed according to international guidelines

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026